Cargando…
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
BACKGROUND: COVID-19 is a respiratory illness caused by SARS-CoV-2. The most recent variant is Omicron (line B.1.1.529), which was first identified in South Africa in November 2021. The concern with this variant is the ineffectiveness of vaccines currently available. We aim to systematically evaluat...
Autores principales: | Zou, Yuntao, Huang, Doudou, Jiang, Qian, Guo, Yanglin, Chen, Chider |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326247/ https://www.ncbi.nlm.nih.gov/pubmed/35910897 http://dx.doi.org/10.3389/fpubh.2022.940956 |
Ejemplares similares
-
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
por: Song, Shangchen, et al.
Publicado: (2023) -
Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
por: Zhang, Jianguo, et al.
Publicado: (2022) -
Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
por: Mella-Torres, Andrea, et al.
Publicado: (2022) -
Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
por: Reynolds, Lia, et al.
Publicado: (2023) -
Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
por: Domínguez-Ramírez, Lenin, et al.
Publicado: (2022)